transforming outcomes in advanced lung cancer: immunotherapy in unselected patients
Published 6 years ago • 74 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
0:32
improving patient-reported outcomes in nsclc
-
3:34
clinical outcomes of immunotherapy after radiographic progression in advanced nsclc
-
2:54
considerations for duration and de-escalation of immunotherapy in lung cancer
-
3:43
immunotherapy for operable lung cancer
-
2:03
antibiotics impact outcomes with pembrolizumab in nsclc patients
-
2:33
lung cancer: post-frontline immunotherapy
-
1:06
improving immunotherapy outcomes in ovarian cancer
-
2:46
unanswered questions in treating lung cancer with immunotherapy
-
2:31
differences in treating lung cancer with adjuvant and neoadjuvant immunotherapy
-
4:15
the toxicities associated with immunotherapy in lung cancer patients
-
1:13
a new standard of care for advanced lung cancer: what’s next for pembrolizumab?
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:52
is adjuvant immunotherapy necessary in non-small cell lung cancer?
-
1:51
future directions for neoadjuvant immunotherapy in lung cancer
-
2:54
best results ever in the treatment of small cell lung cancer: immunotherapy in primary care
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
45:21
advances in immunotherapy & resectable non-small cell lung cancer